A20 regulates the therapeutic effect of anti-PD-1 immunotherapy in melanoma

A20 regulates the therapeutic effect of anti-PD-1 immunotherapy in melanoma

Background The therapeutic effect of immune checkpoint blockers, especially the neutralizing antibodies of programmed cell death (PD-1) and its ligand programmed death ligand 1 (PD-L1), has been well verified in melanoma. Nevertheless, the dissatisfactory response rate and the occurrence of resistan...

Full description

Bibliographic Details
Main Authors: Jingjing Ma, Weinan Guo, Jinyuan Ma, Sen Guo, Huina Wang, Sijia Wang, Qiong Shi, Tao Zhao, Fengfan Yang, Shuyang Chen, Jianru Chen, Jianhong Zhao, Xiuli Yi, Yuqi Yang, Qingrong Ni, Guannan Zhu, Tianwen Gao, Chunying Li
Format: Article
Language:English
Published: BMJ Publishing Group 2020-07-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/8/2/e001866.full

Internet

https://jitc.bmj.com/content/8/2/e001866.full

Similar Items